Interserve plc (IRV) Receives GBX 96.25 Consensus Target Price from Analysts

Share on StockTwits

Shares of Interserve plc (LON:IRV) have earned an average rating of “Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is GBX 96.25 ($1.26).

A number of research firms recently weighed in on IRV. Numis Securities reissued a “buy” rating on shares of Interserve in a research note on Tuesday, August 7th. Peel Hunt reissued a “buy” rating on shares of Interserve in a research note on Tuesday, August 7th. Liberum Capital reissued a “hold” rating on shares of Interserve in a research note on Tuesday, August 7th. Finally, JPMorgan Chase & Co. upped their target price on shares of Interserve from GBX 93 ($1.22) to GBX 95 ($1.24) and gave the company a “neutral” rating in a research note on Wednesday, August 8th.

Shares of LON:IRV traded down GBX 0.80 ($0.01) on Monday, hitting GBX 50.65 ($0.66). 217,157 shares of the company were exchanged, compared to its average volume of 2,640,000. Interserve has a one year low of GBX 52.75 ($0.69) and a one year high of GBX 249.75 ($3.26).

About Interserve

Interserve Plc provides advice, design, construction, equipment, facilities management, and citizen services in the United Kingdom and internationally. Its Support Services segment offers support services to public- and private-sector clients. The company's Construction segment designs, constructs, and maintains buildings and infrastructure.

See Also: The Role of a Fiduciary and Individual Investors

Analyst Recommendations for Interserve (LON:IRV)

Receive News & Ratings for Interserve Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interserve and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.